Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by chrispion Jul 16, 2021 11:33am
107 Views
Post# 33559596

RE:RE:Man! Interest In This Stock Is Jumping!

RE:RE:Man! Interest In This Stock Is Jumping!

Finallytherock wrote: Despite recent news and data (albeit, very little details which is pathetic by this company) and the promotion i have been seeing on twitter, the stock price still languishes. It appears most on this board are no longer interested either based on the lack of posts. Some of the long timers don't see to be here anymore. The company is really all fluff at this point. They have yet to produce anything substantial in all of these years. The fact that they have nothing in the clinic after touting their platform for so many years is shameful. The stock price continues to suffer and the volume shows no one cares. Maybe if they can produce something from prothena or chiasi we will see something change but the market is saying they don't care and the ceo continues to flounder


I'm still here.

All the major shareholders are still here.

We still believe great things are in store for the company and that the remainder of the year will be prosperous for shareholders.

It's the summer time when all stock trading volumes are slower.

One new study result does not a company make ... but maybe an additional one ... maybe an additional two ... maybe a licensing deal after that ... maybe another licensing deal after that ... (get the picture ;)

<< Previous
Bullboard Posts
Next >>